RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

 
  • Regulatory NewsRegulatory News

    MHRA to Land a New Interim Chief Executive Ahead of Brexit

    Beginning 20 September, June Raine will be the new interim Chief Executive of the Medicines and Healthcare products Regulatory Agency (MHRA). Raine will replace Ian Hudson, who will step down after 18 years with MHRA, including six years as chief executive. In addition to Hudson, John Wilkinson, director of devices at MHRA, will step down at the end of October. In June, Wilkinson discussed with Focus several initiatives that MHRA is working on, including how to de...
  • EMA Appoints Leaders of Newly-Formed Pharmacovigilance Committee

    The European Medicines Agency (EMA) has announced the appointment of the chair and vice chair of its newest committee, the Pharmacovigilance Risk Assessment Committee (PRAC), which is set to oversee newly implemented pharmacovigilance measures in the EU. The PRAC was formed to replace the now-defunct Pharmacovigilance Working Party (PHVWP). In a July statement, EMA said the PHVWP had completed its original charge, which was in its possession since the agency's founding...